Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Isotechnika Pharma Inc IPHAF



GREY:IPHAF - Post by User

Bullboard Posts
Comment by culateron Jul 02, 2008 5:19pm
409 Views
Post# 15251334

RE: RBC drops target to $3 from $4

RE: RBC drops target to $3 from $4

Claritas, you are on the same party line and of course my owning shares in this company I would appreciate any positive input from any source.  My point is that without any change in information regarding the drug or the company the analyst changes their guess, and that is all it is.   We as well can only guess.  My guess is the only thing that matters at this point is that Roche backs the drug.   If they don't it will be a drop in share price and a very long, long recovery.   The drug has proven to work and probably better than worms.

culater

Bullboard Posts